Wordt geladen...
A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-to-Severe Psoriasis
INTRODUCTION: Psoriasis is a chronic immune-mediated inflammatory skin disease that occurs in 2.5–3.5% of the general population. Infliximab (INF), a TNF-α inhibitor biologic agent, is a long-standing efficacious treatment for psoriasis; however, not all patients sustain a long-term response (LTR) b...
Bewaard in:
| Gepubliceerd in: | Dermatol Ther (Heidelb) |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Healthcare
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7477063/ https://ncbi.nlm.nih.gov/pubmed/32816254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-020-00436-1 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|